Mind Cure Health (MCUR.C) announced the development of two proprietary ketamine-enhanced protocols specifically for pain management and another for depression, according to a press release. Depression is basically…
iSTRYM
Mind Cure (MCUR.C), a leader in advanced proprietary technology for psychedelic therapy, has provided updates regarding its financial position, near-term revenue strategy, and a timeline for iSTRYM’s market launch….
Mind Cure Health (MCUR.C) has entered into a partnership with Speak Ai to bolster the Company’s iSTRYM platform. “We are proud to partner with MINDCURE today to help build…
Mind Cure (MCUR.C) has filed a provisional patent application with the U.S. Patent and Trademark Office for the Company’s iSTRYM proprietary digital therapeutics (DTx) tool. “When people think of…
Mind Cure Health (MCUR.C) launched iSTRYM, a digital therapeutic tool for providing data regarding patient care, procedures and protocols, as well as other resources for mental health care workers…